Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.
Saad M, Lesage S, Saint-Pierre A, Corvol JC, Zelenika D, Lambert JC, Vidailhet M, Mellick GD, Lohmann E, Durif F, Pollak P, Damier P, Tison F, Silburn PA, Tzourio C, Forlani S, Loriot MA, Giroud M, Helmer C, Portet F, Amouyel P, Lathrop M, Elbaz A, Durr A, Martinez M, Brice A; French Parkinson's Disease Genetics Study Group. Saad M, et al. Among authors: pollak p. Hum Mol Genet. 2011 Feb 1;20(3):615-27. doi: 10.1093/hmg/ddq497. Epub 2010 Nov 17. Hum Mol Genet. 2011. PMID: 21084426
G2019S LRRK2 mutation in French and North African families with Parkinson's disease.
Lesage S, Ibanez P, Lohmann E, Pollak P, Tison F, Tazir M, Leutenegger AL, Guimaraes J, Bonnet AM, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group. Lesage S, et al. Among authors: pollak p. Ann Neurol. 2005 Nov;58(5):784-7. doi: 10.1002/ana.20636. Ann Neurol. 2005. PMID: 16240353
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.
Lesage S, Dürr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A; French Parkinson's Disease Genetics Study Group. Lesage S, et al. Among authors: pollak p. N Engl J Med. 2006 Jan 26;354(4):422-3. doi: 10.1056/NEJMc055540. N Engl J Med. 2006. PMID: 16436781 No abstract available.
LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
Lesage S, Janin S, Lohmann E, Leutenegger AL, Leclere L, Viallet F, Pollak P, Durif F, Thobois S, Layet V, Vidailhet M, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group; Bonnet AM, Borg M, Broussolle E, Damier P, Destée A, Martinez M, Penet C, Rasco O, Tison F, Tranchan C, Vérin M. Lesage S, et al. Among authors: pollak p. Arch Neurol. 2007 Mar;64(3):425-30. doi: 10.1001/archneur.64.3.425. Arch Neurol. 2007. PMID: 17353388
Are parkin patients particularly suited for deep-brain stimulation?
Lohmann E, Welter ML, Fraix V, Krack P, Lesage S, Laine S, Tanguy ML, Houeto JL, Mesnage V, Pollak P, Durr A, Agid Y, Brice A; French Parkinson's Disease Genetics study group. Lohmann E, et al. Among authors: pollak p. Mov Disord. 2008 Apr 15;23(5):740-3. doi: 10.1002/mds.21903. Mov Disord. 2008. PMID: 18228569
A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
Ribeiro MJ, Thobois S, Lohmann E, du Montcel ST, Lesage S, Pelissolo A, Dubois B, Mallet L, Pollak P, Agid Y, Broussolle E, Brice A, Remy P; French Parkinson's Disease Genetics Study Group. Ribeiro MJ, et al. Among authors: pollak p. J Nucl Med. 2009 Aug;50(8):1244-50. doi: 10.2967/jnumed.109.063529. Epub 2009 Jul 17. J Nucl Med. 2009. PMID: 19617340 Free article.
477 results